Acadian Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,276
Closed -$37K 2263
2024
Q3
$37K Buy
+7,276
New +$37K ﹤0.01% 1887
2017
Q2
Sell
-35,338
Closed -$735K 1618
2017
Q1
$735K Buy
+35,338
New +$735K ﹤0.01% 814